Advertisement
Loading...

Nexera Technologies Ltd

NEXR•NASDAQ
Healthcare
Biotechnology
$1.40
$0.24(20.69%)
U.S. Market opens in 65h 22m
Advertisement

Nexera Technologies Ltd (NEXR) Stock Overview

Explore Nexera Technologies Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap914.3K
P/E Ratio-0.08
EPS (TTM)$-86.23
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

NEXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nexera Technologies Ltd (NEXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.08 and a market capitalization of 914.3K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.45%
5-Day Change
-4.13%
1-Month Change
-49.57%
3-Month Change
-70.56%
6-Month Change
-70.56%
Year-to-Date (YTD) Change
-70.56%
1-Year Change
-70.56%
3-Year Change
-70.56%
5-Year Change
-70.56%
All-Time (Max) Change
-70.56%

Contact Information

https://nexera-tech.io
972 3 771 3520
7 Mezada Street, Bnei Brak, NaN, 5126112

Company Facts

11 Employees
IPO DateApr 2, 2026
CountryIL
Actively Trading

Frequently Asked Questions